<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36680296</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>16</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Subjective and Objective Cognitive Impairments in Non-Hospitalized Persons 9 Months after SARS-CoV-2 Infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">256</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v15010256</ELocationID><Abstract><AbstractText>Studies on cognitive problems of persons with mild COVID-19 courses are still lacking. This study aimed to determine the frequency and associated factors of subjective and objective cognitive problems after COVID-19 in non-hospitalized persons. Study participants were examined at the University Hospital of Augsburg from 04/11/2020 to 26/05/2021. The Wechsler Adult Intelligence Scale (WAIS) IV digit span, Stroop Color and Word Test (SCWT), Regensburger verbal fluency test (RWT) and, subjective ratings of memory and concentration were applied. Of the 372 participants (mean age 46.8 &#xb1; 15.2 years, 54.3% women, median time after infection 9.1 months), 24.9% reported concentration and 21.9% memory problems. Overall, 55.6% of the participants had at least a mild negative alteration in any cognitive test. The strongest impairments were found regarding memory functions (41.1% mild alterations, 6.2% distinct impairments) and verbal fluency (12.4% mild alterations, 5.4% distinct impairments). SCWT showed negative alterations in no more than 3.0% of the participants. Level of school education, age, and depressiveness emerged as significantly related to the cognitive tests. The number of complaints and depressiveness were significantly associated with subjective memory and concentration problems. It is important to identify mild cognitive impairment in non-hospitalized COVID-19 patients early to offer them effective interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kirchberger</LastName><ForeName>Inge</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-1967-709X</Identifier><AffiliationInfo><Affiliation>Epidemiology, Faculty of Medicine, University of Augsburg, University Hospital of Augsburg, Stenglinstra&#xdf;e 2, 86156 Augsburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Information Processing, Biometry and Epidemiology-IBE, LMU Munich, 81377 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peilst&#xf6;cker</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Epidemiology, Faculty of Medicine, University of Augsburg, University Hospital of Augsburg, Stenglinstra&#xdf;e 2, 86156 Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warm</LastName><ForeName>Tobias D</ForeName><Initials>TD</Initials><Identifier Source="ORCID">0000-0003-0114-2425</Identifier><AffiliationInfo><Affiliation>Vascular Surgery, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linseisen</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9386-382X</Identifier><AffiliationInfo><Affiliation>Epidemiology, Faculty of Medicine, University of Augsburg, University Hospital of Augsburg, Stenglinstra&#xdf;e 2, 86156 Augsburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Information Processing, Biometry and Epidemiology-IBE, LMU Munich, 81377 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyhlik-D&#xfc;rr</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Vascular Surgery, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meisinger</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Epidemiology, Faculty of Medicine, University of Augsburg, University Hospital of Augsburg, Stenglinstra&#xdf;e 2, 86156 Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Go&#xdf;lau</LastName><ForeName>Yvonne</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9522-5864</Identifier><AffiliationInfo><Affiliation>Vascular Surgery, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">cognition</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">memory</Keyword><Keyword MajorTopicYN="N">outpatients</Keyword><Keyword MajorTopicYN="N">post COVID</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>1</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36680296</ArticleId><ArticleId IdType="pmc">PMC9865483</ArticleId><ArticleId IdType="doi">10.3390/v15010256</ArticleId><ArticleId IdType="pii">v15010256</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID-19 Map&#x2014;Johns Hopkins Coronavirus Resource Center [updated 24 May 2022]  [(accessed on 24 May 2022)].  Available online:  https://coronavirus.jhu.edu/map.html.</Citation></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients with COVID-19: A Systematic Review. JAMA Netw. Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pietro D.A., Comini L., Gazzi L., Luisa A., Vitacca M. Neuropsychological Pattern in a Series of Post-Acute COVID-19 Patients in a Rehabilitation Unit: Retrospective Analysis and Correlation with Functional Outcomes. Int. J. Environ. Res. Public Health. 2021;18:5917. doi: 10.3390/ijerph18115917.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18115917</ArticleId><ArticleId IdType="pmc">PMC8198028</ArticleId><ArticleId IdType="pubmed">34072951</ArticleId></ArticleIdList></Reference><Reference><Citation>Dix E., Roy K. COVID-19: Brain Effects. Psychiatr. Clin. N. Am. 2022;45:625&#x2013;637. doi: 10.1016/j.psc.2022.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psc.2022.07.009</ArticleId><ArticleId IdType="pmc">PMC9257090</ArticleId><ArticleId IdType="pubmed">36396269</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodagar A., Javed R., Tahir H., Razak S.I.A., Shakir M., Naeem M., Yusof A.H.A., Sagadevan S., Hazafa A., Uddin J., et al. Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches. Biomolecules. 2022;12:971. doi: 10.3390/biom12070971.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12070971</ArticleId><ArticleId IdType="pmc">PMC9313047</ArticleId><ArticleId IdType="pubmed">35883527</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares-J&#xfa;nior J.W., de Souza A.C.C., Borges J.W.P., Oliveira D.N., Siqueira-Neto J.I., Sobreira-Neto M.A., Braga-Neto P. COVID-19 associated cognitive impairment: A systematic review. Cortex. 2022;152:77&#x2013;97. doi: 10.1016/j.cortex.2022.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2022.04.006</ArticleId><ArticleId IdType="pmc">PMC9014565</ArticleId><ArticleId IdType="pubmed">35537236</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L., Palmer K., Calandri I., Guekht A., Beghi E., Carroll W., Frontera J., Garc&#xed;a-Azor&#xed;n D., Westenberg E., Winkler A.S., et al. Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis. Alzheimers Dement. 2022;18:1047&#x2013;1066. doi: 10.1002/alz.12644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12644</ArticleId><ArticleId IdType="pmc">PMC9073922</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovitz B., Jaywant A., Fridman C.B. Neuropsychological functioning in severe acute respiratory disorders caused by the coronavirus: Implications for the current COVID-19 pandemic. Clin. Neuropsychol. 2020;34:1453&#x2013;1479. doi: 10.1080/13854046.2020.1803408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2020.1803408</ArticleId><ArticleId IdType="pubmed">32901580</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Chesney E., Oliver D., Pollak T.A., McGuire P., Fusar-Poli P., Zandi M.S., Lewis G., David A.S. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611&#x2013;627. doi: 10.1016/S2215-0366(20)30203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel S.A.M., Olde Hartman T.C., Lucassen P.L.B.J., van Jaarsveld C.H.M. Post-acute and long-COVID-19 symptoms in patients with mild diseases: A systematic review. Fam. Pract. 2021;39:159&#x2013;167. doi: 10.1093/fampra/cmab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker J.H., Lin J.J., Doernberg M., Stone K., Navis A., Festa J.R., Wisnivesky J.P. Assessment of Cognitive Function in Patients After COVID-19 Infection. JAMA Netw. Open. 2021;4:e2130645. doi: 10.1001/jamanetworkopen.2021.30645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.30645</ArticleId><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-S&#xe1;nchez C., Calabria M., Grunden N., Pons C., Arroyo J.A., G&#xf3;mez-Anson B., Lle&#xf3; A., Alcolea D., Belv&#xed;s R., Moroll&#xf3;n N., et al. Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain Behav. 2022;12:e2508. doi: 10.1002/brb3.2508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2508</ArticleId><ArticleId IdType="pmc">PMC8933779</ArticleId><ArticleId IdType="pubmed">35137561</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg S., Kim L., Whitaker M., O&#x2019;Halloran A., Cummings C., Holstein R., Prill M., Chai S.J., Kirley P.D., Alden N.B., et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019&#x2014;COVID-NET, 14 States, March 1&#x2013;30, 2020. Morb. Mortal. Wkly. Rep. 2020;69:458&#x2013;464. doi: 10.15585/mmwr.mm6915e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6915e3</ArticleId><ArticleId IdType="pmc">PMC7755063</ArticleId><ArticleId IdType="pubmed">32298251</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus SARS-CoV-2&#x2014;COVID-19-F&#xe4;lle Nach Meldewoche und Geschlecht Sowie Anteile Mit f&#xdc;r COVID-19 Relevanten Symptomen, Anteile Hospitalisierter/Verstorbener und Altersmittelwert/-median (Tabelle Wird Jeden Donnerstag Aktualisiert)  [(accessed on 24 May 2022)].  Available online:  https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Daten/Klinische_Aspekte.html.</Citation></Reference><Reference><Citation>Vanderlind W.M., Rabinovitz B.B., Miao I.Y., Oberlin L.E., Bueno-Castellano C., Fridman C., Jaywant A., Kanellopoulos D. A systematic review of neuropsychological and psychiatric sequalae of COVID-19: Implications for treatment. Curr. Opin. Psychiatry. 2021;34:420&#x2013;433. doi: 10.1097/YCO.0000000000000713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/YCO.0000000000000713</ArticleId><ArticleId IdType="pmc">PMC8183238</ArticleId><ArticleId IdType="pubmed">34016818</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker H.A., Safavynia S.A., Evered L.A. The &#x2018;third wave&#x2019;: Impending cognitive and functional decline in COVID-19 survivors. Br. J. Anaesth. 2021;126:44&#x2013;47. doi: 10.1016/j.bja.2020.09.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.09.045</ArticleId><ArticleId IdType="pmc">PMC7577658</ArticleId><ArticleId IdType="pubmed">33187638</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Trender W., Chamberlain S.R., Jolly A.E., Grant J.E., Patrick F., Mazibuko N., Williams S.C., Barnby J.M., Hellyer P., et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39:101044. doi: 10.1016/j.eclinm.2021.101044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L., Calandri I., Corval&#xe1;n N., Carello M.A., Keller G., Mart&#xed;nez C., Arruabarrena M., Allegri R. Cognitive consequences of COVID-19: Results of a cohort study from South America. Arq Neuropsiquiatr. 2022;80:240&#x2013;247. doi: 10.1590/0004-282x-anp-2021-0320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282x-anp-2021-0320</ArticleId><ArticleId IdType="pmc">PMC9648931</ArticleId><ArticleId IdType="pubmed">34816972</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K.W., Johnsen S., Sattler S.M., Nielsen S., Kunalan K., Rungby J., Lapperre T., Porsberg C.M. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur. Neuropsychopharmacol. 2021;46:39&#x2013;48. doi: 10.1016/j.euroneuro.2021.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.03.019</ArticleId><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano R.F., Guedes B.F., de Rocca C.C., de P&#xe1;dua Serafim A., Castro L.H.M., Munhoz C.D., Nitrini R., Filho G.B., Miguel E.C., Lucchetti G., et al. Cognitive decline following acute viral infections: Literature review and projections for post-COVID-19. Eur. Arch. Psychiatry Clin. Neurosci. 2022;272:139&#x2013;154. doi: 10.1007/s00406-021-01286-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-021-01286-4</ArticleId><ArticleId IdType="pmc">PMC8231753</ArticleId><ArticleId IdType="pubmed">34173049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K., Spitzer R.L., Williams J.B.W., L&#xf6;we B. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: A systematic review. Gen. Hosp. Psychiatry. 2010;32:345&#x2013;359. doi: 10.1016/j.genhosppsych.2010.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2010.03.006</ArticleId><ArticleId IdType="pubmed">20633738</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner R., Hagl M. Die revidierte Impact of Event-Skala (IES-R) Psychosom. Konsiliarpsychiatr. 2008;2:240&#x2013;243. doi: 10.1007/s11800-008-0132-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11800-008-0132-2</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;ppe M., Schneider K., Casser H.R., Knille A., Kohlmann T., Lindena G., Nagel B., Nelles J., Pfingsten M., Petzke F. Kennwerte und teststatistische G&#xfc;te des Veterans RAND 12-Item Health Survey (VR-12) bei Patienten mit chronischem Schmerz: Eine Auswertung auf Basis des KEDOQ-Schmerz-Datensatzes. Der Schmerz. 2021;6:109&#x2013;120. doi: 10.1007/s00482-021-00570-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00482-021-00570-5</ArticleId><ArticleId IdType="pmc">PMC8956556</ArticleId><ArticleId IdType="pubmed">34279750</ArticleId></ArticleIdList></Reference><Reference><Citation>Petermann F. Wechsler Adult Intelligence Scale. 4th ed. Pearson; London, UK: 2021.</Citation></Reference><Reference><Citation>B&#xe4;umler G. Farb-Wort-Interferenztest (FWIT) nach J. R. Stroop. Hogrefe; G&#xf6;ttingen, Germany: 1985.</Citation></Reference><Reference><Citation>Aschenbrenner S., Tucha O., Lange K.W. RWT. Regensburger Wortfl&#xfc;ssigkeits-Test. Hogrefe; G&#xf6;ttingen, Germany: 2001.</Citation></Reference><Reference><Citation>Scarpina F., Tagini S. The Stroop Color and Word Test. Front. Psychol. 2017;8:557. doi: 10.3389/fpsyg.2017.00557.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2017.00557</ArticleId><ArticleId IdType="pmc">PMC5388755</ArticleId><ArticleId IdType="pubmed">28446889</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H., Doucet L., Berkani S., Oliosi E., Mallart E., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020;81:e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannan A., Mehedi H.M.H., Chy N.U.H.A., Qayum M.O., Akter F., Rob M.A., Biswas P., Hossain S., Ayub M. A multi-centre, cross-sectional study on coronavirus disease 2019 in Bangladesh: Clinical epidemiology and short-term outcomes in recovered individuals. New Microbes New Infect. 2021;40:100838. doi: 10.1016/j.nmni.2021.100838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2021.100838</ArticleId><ArticleId IdType="pmc">PMC7834423</ArticleId><ArticleId IdType="pubmed">33520252</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattioli F., Stampatori C., Righetti F., Sala E., Tomasi C., de Palma G. Neurological and cognitive sequelae of Covid-19: A four month follow-up. J. Neurol. 2021;268:4422&#x2013;4428. doi: 10.1007/s00415-021-10579-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10579-6</ArticleId><ArticleId IdType="pmc">PMC8088203</ArticleId><ArticleId IdType="pubmed">33932157</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogueira J., Gerardo B., Silva A.R., Pinto P., Barbosa R., Soares S., Baptista B., Paquete C., Cabral-Pinto M., Vilar M.M., et al. Effects of restraining measures due to COVID-19: Pre- and post-lockdown cognitive status and mental health. Curr. Psychol. 2021;41:7383&#x2013;7392. doi: 10.1007/s12144-021-01747-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12144-021-01747-y</ArticleId><ArticleId IdType="pmc">PMC8057859</ArticleId><ArticleId IdType="pubmed">33897227</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto O.H., Rumbea D.A., Recalde B.Y., Mera R.M. Cognitive sequelae of long COVID may not be permanent: A prospective study. Eur. J. Neurol. 2022;29:1218&#x2013;1221. doi: 10.1111/ene.15215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15215</ArticleId><ArticleId IdType="pubmed">34918425</ArticleId></ArticleIdList></Reference><Reference><Citation>Albu S., Zozaya N.R., Murillo N., Garc&#xed;a-Molina A., Chac&#xf3;n C.A.F., Kumru H. What&#x2019;s going on following acute covid-19? Clinical characteristics of patients in an out-patient rehabilitation program. NeuroRehabilitation. 2021;48:469&#x2013;480. doi: 10.3233/NRE-210025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/NRE-210025</ArticleId><ArticleId IdType="pubmed">33998551</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaywant A., Vanderlind W.M., Alexopoulos G.S., Fridman C.B., Perlis R.H., Gunning F. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology. 2021;46:2235&#x2013;2240. doi: 10.1038/s41386-021-00978-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-021-00978-8</ArticleId><ArticleId IdType="pmc">PMC7884062</ArticleId><ArticleId IdType="pubmed">33589778</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., Palladini M., De Lorenzo R., Magnaghi C., Poletti S., Furlan R., Ciceri F., COVID-19 BioB Outpatient Clinic Study group. Rovere-Querini P., Benedetti F. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 2021;94:138&#x2013;147. doi: 10.1016/j.bbi.2021.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V., Beer R., Schiefecker A.J., Kofler M., Lindner A., Mahlknecht P., Heim B., Limmert V., Sahanic S., Pizzini A., et al. Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study. Eur. J. Neurol. 2021;28:3348&#x2013;3359. doi: 10.1111/ene.14803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14803</ArticleId><ArticleId IdType="pmc">PMC8250725</ArticleId><ArticleId IdType="pubmed">33682276</ArticleId></ArticleIdList></Reference><Reference><Citation>Negrini F., Ferrario I., Mazziotti D., Berchicci M., Bonazzi M., de Sire A., Negrini S., Zapparoli L. Neuropsychological Features of Severe Hospitalized Coronavirus Disease 2019 Patients at Clinical Stability and Clues for Postacute Rehabilitation. Arch. Phys. Med. Rehabil. 2021;102:155&#x2013;158. doi: 10.1016/j.apmr.2020.09.376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2020.09.376</ArticleId><ArticleId IdType="pmc">PMC7521874</ArticleId><ArticleId IdType="pubmed">32991870</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeria M., Cejudo J.C., Sotoca J., Deus J., Krupinski J. Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment. Brain Behav. Immun. Health. 2020;9:100163. doi: 10.1016/j.bbih.2020.100163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100163</ArticleId><ArticleId IdType="pmc">PMC7581383</ArticleId><ArticleId IdType="pubmed">33111132</ArticleId></ArticleIdList></Reference><Reference><Citation>Amalakanti S., Arepalli K.V.R., Jillella J.P. Cognitive assessment in asymptomatic COVID-19 subjects. Virusdisease. 2021;32:146&#x2013;149. doi: 10.1007/s13337-021-00663-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13337-021-00663-w</ArticleId><ArticleId IdType="pmc">PMC7883942</ArticleId><ArticleId IdType="pubmed">33614860</ArticleId></ArticleIdList></Reference><Reference><Citation>Bungenberg J., Humkamp K., Hohenfeld C., Rust M.I., Ermis U., Dreher M., Hartmann N.K., Marx G., Binkofski F., Finke C., et al. Long COVID-19: Objectifying most self-reported neurological symptoms. Ann. Clin. Transl. Neurol. 2022;9:141&#x2013;154. doi: 10.1002/acn3.51496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51496</ArticleId><ArticleId IdType="pmc">PMC8862437</ArticleId><ArticleId IdType="pubmed">35060361</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>